Trade Sartorius Stedim Biotech SA - DIM CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.88 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.022099% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.000123% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | France | ||||||||
| Commission on trade | 0% |
| Prev. Close | 207.55 |
| Open | 206.75 |
| 1-Year Change | -20.69% |
| Day's Range | 204.36 - 206.75 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2024 | 207.55 | -0.20 | -0.10% | 207.75 | 212.54 | 207.25 |
| Apr 23, 2024 | 209.25 | 13.43 | 6.86% | 195.82 | 210.25 | 192.52 |
| Apr 22, 2024 | 197.32 | -3.74 | -1.86% | 201.06 | 201.46 | 190.78 |
| Apr 19, 2024 | 200.56 | -3.10 | -1.52% | 203.66 | 204.66 | 194.87 |
| Apr 18, 2024 | 209.05 | 0.20 | 0.10% | 208.85 | 219.23 | 200.76 |
| Apr 17, 2024 | 248.59 | -2.19 | -0.87% | 250.78 | 251.18 | 246.19 |
| Apr 16, 2024 | 249.88 | 0.10 | 0.04% | 249.78 | 252.58 | 247.79 |
| Apr 15, 2024 | 253.58 | 4.99 | 2.01% | 248.59 | 257.47 | 247.29 |
| Apr 12, 2024 | 249.98 | -3.30 | -1.30% | 253.28 | 258.67 | 249.08 |
| Apr 11, 2024 | 253.58 | 2.70 | 1.08% | 250.88 | 254.18 | 249.19 |
| Apr 10, 2024 | 252.08 | -9.48 | -3.62% | 261.56 | 261.56 | 249.19 |
| Apr 9, 2024 | 259.97 | 6.69 | 2.64% | 253.28 | 260.97 | 253.28 |
| Apr 8, 2024 | 255.67 | 8.09 | 3.27% | 247.58 | 257.57 | 247.58 |
| Apr 5, 2024 | 251.98 | 2.60 | 1.04% | 249.38 | 252.48 | 247.79 |
| Apr 4, 2024 | 256.77 | 0.80 | 0.31% | 255.97 | 258.57 | 252.38 |
| Apr 3, 2024 | 256.27 | 0.20 | 0.08% | 256.07 | 257.27 | 250.18 |
| Apr 2, 2024 | 257.17 | -4.40 | -1.68% | 261.57 | 261.57 | 254.28 |
| Mar 28, 2024 | 265.56 | 3.10 | 1.18% | 262.46 | 268.16 | 261.07 |
| Mar 27, 2024 | 259.77 | -6.79 | -2.55% | 266.56 | 268.65 | 254.28 |
| Mar 26, 2024 | 267.96 | -2.59 | -0.96% | 270.55 | 271.55 | 266.56 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Sartorius Stedim Biotech Company profile
About Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The Company operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Sartorius Stedim Biotech SA revenues increased 51% to EUR2.89B. Net income applicable to common stockholders increased 23% to EUR414.4M. Revenues reflect EMEA segment increase of 60% to EUR829.1M, United States segment increase of 41% to EUR895.3M. Net income was partially offset by Financial Expense - Balancing value decrease from EUR1K (income) to EUR212.3M (expense).
Equity composition
07/2007, Company name changed from Stedim S.A. 05/2016, Scrip Issue, (Factor:5.99988).
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
Zone Industrielle les Paluds Avenue de Jouques
Bp 1051
AUBAGNE
PACA 13781
FR
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com